Standout Papers

Tirzepatide Once Weekly for the Treatment of Obesity 2022 2026 2023 20241.5k
  1. Tirzepatide Once Weekly for the Treatment of Obesity (2022)
    Ania M. Jastreboff, Louis J. Aronne et al. New England Journal of Medicine
  2. Tirzepatide for Obesity Treatment and Diabetes Prevention (2024)
    Ania M. Jastreboff, Carel W. le Roux et al. New England Journal of Medicine
  3. Body composition changes during weight reduction with tirzepatide in the SURMOUNT ‐1 study of adults with obesity or overweight (2025)
    Michelle Look, Julia P. Dunn et al. Diabetes Obesity and Metabolism

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 55 standout
Sub-graph 1 of 24

Citing Papers

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
2025 Standout

Works of Adam Stefański being referenced

Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout

Author Peers

Author Last Decade Papers Cites
Adam Stefański 1308 846 800 61 2.6k
Adie Viljoen 1775 683 475 96 3.1k
Giuseppe Seghieri 1262 264 548 114 3.2k
Camila Manrique 998 252 709 51 2.6k
Franco Cavalot 2071 368 819 117 4.1k
G. Buzzigoli 1310 299 1148 50 3.1k
William Jubiz 725 413 502 91 3.2k
Mojca Jensterle 1025 438 222 111 2.4k
Paolo Cavallo Perin 854 340 291 77 3.1k
Dimitrios N. Kiortsis 769 397 599 96 3.1k
P Vague 1715 466 898 95 4.2k

All Works

Loading papers...

Rankless by CCL
2026